Genmab — Februar 2018
-
SeaGen, Pieris ink deal for bispecific I/O drugs https://www.biopharmadive.com/news/seagen-pieris-ink-deal-for-bispecific-io-drugs/516764/
-
Expert Highlights Early Promise of Selinexor in Myeloma http://www.onclive.com/web-exclusives/expert-highlights-early-promise-of-selinexor-in-myeloma
-
God morgen.
-
Tak Vitus. Er på arbejde alle ugens 7 dage. Derfor har jeg også morgenhilsen på søndage.
-
https://www.utrechtsciencepark.nl/en/home/about-the-park/news/meet-the-ceo-of-europes-largest-most-fiercely-independent-biotech Er der stadig planer om en tur til Holland?
-
royal...Det er der stadig planer om.
-
God morgen.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind